Another study finds atypicals risky

Atypical antipsychotic double patients' risk of dying from sudden heart failure, a study has found. It's the latest in a succession of reports contradicting the long-held assumption that the new drugs--which include Johnson & Johnson's Risperdal, Eli Lilly's Zyprexa and AstraZeneca's Seroquel--are safer than the older and much less expensive medications that they replaced. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.